Frederic G Barr

9PUBLICATIONS
84CO-AUTHORS
Solid tumoursCellular nervous systemLiquid biopsiesPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 17, 2026
MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma.

|Apr 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

|Mar 14, 2026
Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.

Frederic G Barr

|Nov 20, 2025
Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma.

Salah Boudjadi, Hana Kim, Bishwanath Chatterjee

|Jan 15, 2025
DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models.

Wenyue Sun, Stephen M Hewitt, Hollis Wright

|Sep 21, 2023
Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.

Kay Nakazawa, Taryn Shaw, Young K Song

Pageof 2

Frequent Collaborators

5 joint publications

Wenyue Sun

3 joint publications

Salah Boudjadi

3 joint publications

Pawan Kumar Raut

3 joint publications

Hana Kim